AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹171 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹171 Cr |
| Mar2024 | ₹166 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹141 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹171 Cr | 3.07 | |
| Mar2024 | ₹166 Cr | -18.89 | |
| Mar2023 | ₹205 Cr | -26.88 | |
| Mar2022 | ₹280 Cr | 98.31 | |
| Mar2021 | ₹141 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,733.3 Cr | -3.3% | 9.1% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -3.3% |
9.1% |
-20.4% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses